At a glance
ClinicalIndex Comparison RecordN/ACompleted· 126 enrolled
Drug / intervention
Xenon contrast agent +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
In Brief
A clinical study evaluating Xenon contrast agent and Magnetic Resonance Imaging for Cerebrovascular Accident and Moyamoya Disease. Completed, enrolled 126 participants across 1 site.
Detailed Summary
Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya disease and stroke patients
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Accident, Moyamoya Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedAug 2011
Primary CompletionNov 2013
TodayJul 2026
First PostedAug 18, 2011
Enrollment StartApr 1, 2009
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 14.9 years ago
Interventions
Xenon contrast agentdrug
Magnetic Resonance Imagingdevice
Arterial spin label sequence for the purpose of measuring collateral flow